Kidney TransplantationImmunosuppressive AgentsGraft RejectionTacrolimusCyclosporineHeart TransplantationLung TransplantationTransplantationLiver TransplantationTransplantsTransplantation, HomologousMycophenolic AcidGraft SurvivalOrgan TransplantationPostoperative ComplicationsTissue DonorsCytomegalovirus InfectionsImmunosuppressionBone Marrow TransplantationTime FactorsBK VirusImmunocompromised HostRetrospective StudiesPolyomavirus InfectionsTreatment OutcomeTransplantation ImmunologyKidney Failure, ChronicCyclosporinsDrug MonitoringBronchiolitis ObliteransHeart-Lung TransplantationCytomegalovirusLiving DonorsTablets, Enteric-CoatedSirolimusLiver FailureCalcineurinFollow-Up StudiesGingival OvergrowthBiopsyRisk FactorsHematopoietic Stem Cell TransplantationAntilymphocyte SerumLymphoproliferative DisordersHistocompatibility TestingWaiting ListsPostoperative PeriodCreatinineGanciclovirPancreas TransplantationProspective StudiesKidneyKidney DiseasesAntiviral AgentsTissue and Organ ProcurementIsoantibodiesOpportunistic InfectionsIncidenceDrug Therapy, CombinationGraft vs Host DiseaseEnd Stage Liver DiseaseMycosesMonitoring, ImmunologicAzathioprineRecurrenceRenal DialysisKidney Function TestsGlomerular Filtration RateCadaverTransplantation ToleranceArea Under CurveAcute DiseaseBiological MarkersGingival HyperplasiaIMP DehydrogenasePrednisoneRenal InsufficiencyPostoperative CareAspergillosisLiver DiseasesFetal Tissue TransplantationAntifungal AgentsSurvival AnalysisTransplantation, AutologousHerpesvirus 6, HumanHLA AntigensCytochrome P-450 CYP3APolymerase Chain ReactionTransplantation ConditioningPrimary Graft DysfunctionPrognosisHematologic NeoplasmsSurvival RateCohort StudiesTomography, X-RayMuromonab-CD3ViremiaRisk AssessmentHepatitis CDNA, Viral